The pivotal role of the vascular endothelium in the regulation of vasomotor tone has been recog nised since the original description by Furchgott and Zawadzki (1980a,b) of the obligate role of the endothelium in the vasodilator action of acetylcho line on rabbit aorta. Subsequently, the endothelium has been shown to be responsible for mediating the response to a wide variety of vasoactive agents by the liberation of (possibly several) endothelial de rived relaxing factor(s) and constricting factor(s) (for reviews see Furchgott 1983 Furchgott , 1984 . At least one of these constricting factors is sensitive to the ac tion of proteases (Hickey et aI., 1985; Gillespie et aI., 1986; O'Brien et aI., 1987) . The identification, therefore, by Yanagisawa et a1. (1988) of a 21amino acid peptide (endothelin) with potent vaso constrictor properties from the supernatant medium from cultured porcine aortic endothelial cells has generated much interest. Subsequently, other forms of endothelin varying in their vasoconstrictor ef fects have been described in tissues from other spe cies. At an intracellular level endothelin has been shown to have a variety of effects on calcium stores nanomolar range, with pial veins being slightly more sen sitive to the peptide than pial arterioles. Vasoconstric tions induced by endothelin were extremely prolonged, persisting for �90 min after a single microapplication.
Arterioles constricted by endothelin remained responsive to perivascular microapplication of K + (10 mM) or alkalo tic CSF (pH 7.48). Key Words: Endothelin-Pial ves sels-Vasoconstriction-Vasomotor reactivity. and metabolism (Auguet et aI., 1988; Hirata et aI., 1988; Ishikawa et aI., 1988; Kai et aI., 1988; Miasiro et aI., 1988) and activation of the phosphoinositide pathway (Ambar et aI., 1989; Badr et aI., 1989; Marsden et aI., 1989; Simonson et aI., 1989; Sugiura et aI., 1989) . Endothelin also has been shown to affect peptide release from cells in certain circum stances (Fukuda et aI., 1988; Rakugi et al., 1988; Miller et aI., 1989; Simonson et aI., 1989) . Although initially described as a potent vasoconstrictor, it has more recently been shown in some circumstances to have vasodilator actions as well (Warner et aI., 1989; Wright and Fozard, 1989) . In situ endothelin has potent and prolonged pressor (Yanagisawa et aI., 1988) and inotropic (Ishikawa et aI., 1988) ac tions. In view of the anatomical variation in re sponse to endothelin, we have examined its effects on the cerebral microvasculature in the cat in situ by perivascular microapplication to individual pial vessels and further investigated the influence of al teration of the local ionic environment on vessels following the application of endothelin.
MATERIALS AND METHODS

Surgical preparation
Experiments were performed on eight adult cats of ei ther sex weighing between 2 and 3 kg. Anaesthesia was induced by intravenous injection of Alphaxolonel Alphadolone (Saffan; Glaxo) at a dose of 0.75 mllkg into a radial vein; the vocal cords were sprayed with ligno-caine and the animals were intubated and mechanically ventilated. Both groins were exposed and opened and one femoral artery and both femoral veins dissected free. The vessels were then cannulated and anaesthesia subse quently maintained by intermittent injection of a-chloralose (1% wtlvol solution, 2-4 mUh as required) via one femoral vein. Core temperature was monitored using a rectal temperature probe and maintained using a homeothermic blanket. Mean and phasic blood pressure was continuously monitored and maintained between 80 and 120 mm Hg with Hartmann's solution being infused intravenously as required. Arterial blood was sampled intermittently for blood gas estimation, and blood gases and pH were maintained in the normal range by adjust ment of ventilatory stroke volume or infusion of sodium bicarbonate 8.4% intravenously as required. During sur gical preparation the animals were ventilated on a mixture of nitrous oxide and oxygen (2: 1).
The animal was positioned in a stereotactic frame and following a midline scalp incision the scalp was retracted and stitched to a metal ring to form a well over the cal varium. The pericranium and left temporal muscle were dissected subperiosteally and retracted. With a saline cooled dental drill, a rectangular parietal craniectomy (2.5 x 1.5 cm) was made and extradural haemostasis secured. The exposed dura was bathed with prewarmed mineral oil at 38°C to form a pool not less than 5 mm deep at any point. Under magnification the dura was incised and re flected laterally, bipolar diathermy being used to control bleeding from dural vessels. Once haemostasis was seen to be secure, the inspired gas mixture was changed to oxygen-supplemented air (�25% oxygen) and a period of stabilisation of 30-45 min allowed before the vasomotor study was commenced.
Assessment of vascular diameter
Vascular diameter was measured directly using an im age-splitting video display system (Baez, 1966) . Individ ual pial vessels are viewed using a stereomicroscope, the image passed through an image splitter and thence to a video display. The degree of shear applied to the image is variable, but the amount required to appose tangentially the two images of the vessel is directly proportional to the diameter of the vessel. The system is calibrated using threads of a known diameter and therefore allows direct measurement of the diameter of the vessel in absolute units. Repeated measurements of vessel diameter before and after injections allowed accurate recording of changes in vessel diameter dynamically. Coefficient of variability of measurement was <1%.
Drugs and solutions used
Artificial CSF was made up containing the following (in mM): Na+ 156, K+ 3, Ca 2 + 2.5 , HC03 -12, and Cl-152, taken to pH 7.2 by aeration with 5% C02/95% O2, Solutions containing an excess of 10 mM K + and 22 mM HC03 -in artificial CSF were made by equimolar substi tution of KCI and NaHC03 for NaCl, respectively. En dothelin (porcine: Peninsula Laboratories) was made up in artificial CSF freshly for each experiment at concen trations between 3 x 10 -10 and 3 x 10 -6 M by serial dilutions for derivation of the dose-response curve and at 3 x 10 -8 and 3 x 10 -9 M for experiments on time course and effects of altered local ionic environment.
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Application of drugs
Glass micropipettes with sharpened tips of diameter 8-10 fLm were filled with either CSF, CSF with excess electrolyte, or CSF with peptide and kept under mineral oil until used. The solutions were administered by sub arachnoid microapplication using a micromanipulator to position the tip of the pipette and deliver small volumes (5 fLI) to the immediate perivascular subarachnoid space. To avoid cross-contamination between vessels, all vessels used in any given series of experiments were kept as spa tially separate as possible.
Presentation of results
Changes in vessel diameter are given as mean percent age change ± SEM for the appropriate sample size. Sta tistical analysis was carried out using analysis of variance followed by modified t test with Bonferroni correction for mUltiple comparisons where appropriate (Wallenstein et aI., 1980) .
RESULTS
Effects of endothelin on pial vessels
In these animals artificial CSF was only mlnt mally vasoactive, producing alterations in vessel di ameter of -3.2 ± 1.9% (arteries, n = 9) and -3.7 ± 1.1% (veins, n = 6). Endothelin induced marked dose-dependent vasoconstrictions in pial arterioles ( -33.5 ± 3.8%) and pial veins ( -35.1 ± 2.7%) (Fig.  1) . The concentration of endothelin producing half maximal response was in the nanomolar range for both pial arterioles and veins, with pial veins being slightly more sensitive to the peptide than pial ar terioles. Concentration-response data were ob tained noncumulatively in view of the prolonged re sponse to endothelin (see below). There was no cor relation between preinjection calibre (100-250 ILm for arterioles and 200 �50 ILm for veins) and re sponse at any concentration tested (n = 6--9 for all groups).
Time course of vasomotor response to endothelin
In a separate series of vessels, the duration of vasoconstriction induced by endothelin was as sessed. For these studies concentrations of endo thelin were chosen to give submaximal constric tions of selected vessels. Thus, endothelin at 3 x 10 -8 M was applied to pial arterioles and at 3 x 10-9 M to pial veins. For control purposes similar vessels were selected and CSF applied to these ves sels. The magnitude of vasoconstriction induced by endothelin on these vessels was comparable with that seen in the initial dose-response series above. Arterioles remained significantly vasoconstricted 90 min after a single microapplication of endothelin (Fig. 2) . The time for half-maximal restoration of arteriolar calibre to preinjection levels was -45-60 min. Vasoconstriction in pial veins was similarly prolonged, though there was considerable interves sel variability in individual time courses.
Vasomotor reactivity following endothelin
In a separate series of arterioles, the vasomotor responses to perivascular microapplication of K + and pH (HC03 -22 mM) were examined in arteri oles constricted by prior application of endothelin (3 x 10-8 M). Vasomotor responses to changes in the local ionic microenvironment were assessed �5 min after the application of endothelin.
Arterioles constricted by endothelin retained their capacity to dilate in response to perivascular application of K + (1 0 mM) and their capacity to constrict in response to perivascular application of alkalotic CSF (Fig. 3) . The magnitudes of the vaso motor responses to potassium and pH were similar to those observed in vessels not previously exposed to endothelin, irrespective of how the response was calculated (see legend to Fig. 3) . 
DISCUSSION
It has become accepted since the original work of Furchgott and Zawadzki (1980a,b ) that the vascular endothelium plays a key role in the mediation and regulation of dilator vasomotor stimuli (Furchgott and Zawadzki, 1983, 1984) . This is due to the re lease of (possibly several) endothelial derived relax ing factor(s), one of which has recently been recog nised as nitric oxide (Palmer et al., 1987) . In paral lel, however, more recent evidence shows that the vascular endothelium also plays an essential role in the mediation of some vasoconstrictor influences (Vanhoutte, 1987) . This is thought to be due to the release of (possibly several) endothelial derived constricting factor(s), but none have yet been iden- tified with any degree of certainty. Nevertheless, the demonstration that at least one of these con stricting factors is sensitive to the action of pro teases (Hickey et ai., 1985; Gillespie et ai., 1986; O'Brien et ai., 1987) , together with the identifica tion by Yanagisawa et ai. (1988) of a 21-amino acid peptide (endothelin) with potent vasoconstrictor properties from the supernatant of cultured porcine aortic vascular endothelial cells, have stimulated much interest. As recently noted (Hiley, 1989 ), many early studies have concentrated on the mo lecular biological aspects of the action of endothe lin, functional studies tending to lag behind with demonstration of large-vessel vasoconstriction (Yanagisawa et ai., 1988) , in some tissues vasodila tation (Warner et ai., 1989; Wright and Fozard, 1989) , and positive inotropic, chronotropic, and pressor effects (Ishikawa et ai., 1988; Yanagisawa et ai.,1988) .
The data in the present study are of note for four reasons. First, this report provides confirmation that cerebral blood vessels, like those in the periph eral vasculature, are sensitive to endothelin. Sec ond, the data indicate that arterioles that contribute significant vascular resistance, and thus can influ ence tissue blood flow (McCulloch and Edvinsson, 1984) , constrict when exposed to endothelin in vivo. Third, the cerebral veins, which are the major determinants of cerebrovascular capacitance, are at least as sensitive to endothelin as are pial arterioles. Fourth, the data presented indicate that cerebral vessels constricted by endothelin remain respon sive to other vasomotor stimuli such as alteration in the perivascular concentration of hydrogen or po tassium ions. The potency of endothelin as a cere bral vasoconstrictor stands favourable comparison with all other agents (e.g., neuropeptide Y, nor adrenaline, angiotensin II, etc.) that have been ex amined by the same perivascular microapplication technique (McCulloch and Edvinsson, 1984; Ed vinsson, 1985) . With respect to duration of re sponse, the vasoconstrictions produced by endo thelin markedly exceed those induced by noradren aline or neuropeptide Y (Edvinsson et ai., 1984) and are more persistent than even subarachnoid mi croapplication of arterial blood under the same ex perimental conditions (McCulloch et al., 1986) . The potency of endothelin in producing such intense and prolonged vasoconstriction has fuelled much spec ulation on the physiological role that this peptide may sub serve (Gordon, 1988) . Such speculation must be viewed with caution at the present time.
Although the presence of mRN A encoding a pre cursor of endothelin can be demonstrated in porcine aortic endothelial cells in culture, there are no reli-J Cereb Blood Flow Metab, Vol. ]0, No. 2, 1990 able reports of the presence of endothelin or pre proendothelin mRNA in tissue extracts of brain, lung, or kidney (Yanagisawa et ai., 1988) .
Indeed, it has been suggested that endothelin is not a physiological agent, but a pathological prod uct of damaged endothelial cells. Similarly, al though endothelium-dependent constrictions were first noted in vessels exposed to hypoxia (De Mey and Vanhoutte, 1983; Rubanyi and Vanhoutte, 1985) , the transient nature of these vasoconstric tions contrasts with the relatively slow onset and recovery seen with endothelin. It should be noted that the precise role of endothelial derived relaxing factor in the moment-to-moment regulation of local tissue blood flow remains to be established, despite the detailed pharmacological characterisation of its vasomotor effects in peripheral and cerebral blood vessels.
The present study raises intriguing fundamental questions concerning the regulation of cerebral blood flow. The prevailing view normally attributed to Roy and Sherrington (1890) is that the dominant factors are vasoactive products of cellular metabo lism (e.g., hydrogen and potassium ions, adeno sine). The prolonged vasoconstriction after endo thelin (i.e., the failure of normal homeostatic mech anisms to restore preinjection calibre) together with the preservation of vasomotor reactivity to exoge nous hydrogen and potassium ions suggest that perivascular hydrogen and potassium ions of an en dogenous origin play a minor role in the restoration of pial vessel diameter.
Endothelin is likely to be the focus of major in vestigation irrespective of the role of this new pep tide in cerebrovascular physiology or the insight into cerebrovascular regulation that may be gained from an endothelin challenge. The potency and sus tained duration of cerebral vasoconstriction in duced by endothelin will stimulate interest because of the existence of major clinical problems (sub arachnoid haemorrhage, head injury) in which both vasoconstriction and endothelial damage are fea tures. 
